Screening and treatment for cervical intraepithelial neoplasia (CIN) in HIV-infected women

Minerva Ginecologica

Volumn 54, Issue 4, 2002, Pages 297-307

  Ferrero, S ^a,b   Arena, E ^a   De Masi, E ^a   Biasotti, B ^a   Fulcheri, E ^a   Bentivoglio, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cervical intraepithelial neoplasia, diagnosis; Cervix neoplasms, diagnosis; Colposcopy; HIV 1; Vaginal smears

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS SCREENING; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036673894     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. Lyon, France: IARC, 1995:64.
2. Shiffmann MH, Bauer HM, Hoover RN. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasias. J Natl Cancer Inst 1993;85:958-64.
3. Bosch X, Manos MM, Munoz N. Prevalence of human papillomaviruses in cervical cancer: a world-wide prospective. J Natl Cancer Institute 1995;87:796-802.
4. Bouwes Bavinck JN, Berkhout RJ. HPV infections and immunosuppression. Clin Dermatol 1997;15:427-37.
5. McGregor JM, Proby CM, Leigh IM. Virus infection and cancer risk in transplant recipients. Trends Microbiol 1996;4:2-3.
6. Petry KU, Scheffel D, Bode U. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994;57:836-40.
7. Feingold AR, Vermund SH, Burk RD. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immun Defic Syndr 1990;3:896-903.
8. Laga M, Icenogle JP, Marsella R. Genital papillomavirus infection and cervical dysplasia: opportunistic complications of HIV infection. Int J Cancer 1992;50:45-8.
9. Marte C, Kelly P, Cohen M. Papanicolau smear abnormalities in ambulatory care sites for women infected with human immunodeficiency virus. Am J Obstet Gynecol 1992;166:1232-7.
10. Maiman M, Tarricone N, Vieira J, Suarez J, Serur E, Boyce JG. Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol 1991;78:84-8.
11. Schafer A, Friedmann W, Mielke M, Schwartlander B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with human immunodeficiency virus is related to the degree of immunosuppression. AmJ Obstet Gynecol 1991;164:593-9.
12. Schreger LK, Friedland GH, Maude D. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immun Defic Syndr 1989;2:570-5.
13. Vermund SH, Kelley KF, Klein RS. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991;165:392-400.
14. U. S. Centres for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993;296:729-30.
15. Mandelblatt JS, Fahas M, Garibaldi K, Senie RT, Petersen HB. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS 1992;6:173-8.
16. Palella F, Delaney KM, Moorman AC. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
17. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988. Acta Cytol 1989;33:567-74.
18. Sopracordevok F, Campagnutta E, Parin A, Vaccher E, Volpe R, Scarabelli C. Squamous intraepithelial cervical lesions in human immunodeficiency virus-positive women. J Reprod Med 1996;41:586-90.
19. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW, the Adult/Adolescent Spectrum of HIV Disease Project Group. Effect of antiretroviral theraphy on recent trends in selected cancers among HIV-infected persons. J Acquir Immun Defic Syndr 1999;21:S11-7.
20. Del Priore G, Maag T, Bhattacharya M, Garcia PM, Till M, Lurain JR. The value of cervical cytology in HIV-infected women. Gynecol Oncol 1995;56:395-8.
21. Spinillo A, Capuzzo E, Tenti P, De Santolo A, Piazzi G, Iasci A. Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women. Gynecol Oncol 1998;69:109-13.
22. Wright TC Jr, Ellerbrock TV, Chiasson MA. Cervical intraepithelial neoplasia in women infected with human deficiency virus prevalence, risk factors and validity of Papanicolaou smears. New Jork Cervical Disease Study. Obstet Gynecol 1994;84:591-7.
23. Korn AP, Autry M, DeRemer PA. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:401-4.
24. Koss L. The Papanicolau test for cervical cancer detection: a triumph and a tragedy. JAMA 1989;261:737-43.
25. Wright TC, Moscarelli RD, Dole P, Ellerbrock TV, Chiasson MA, Vandevanter N. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:515-9.
26. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1999;48(RR-10):1-59,61-6.
27. U.S. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47(RR-1): 1-111.
28. Del Mistro A, Insacco E, Cinel A, Bonaldi L, Minucci D, Chieco-Bianchi L. Human papillomavirus infections of the genital region in human immunodeficiency virus seropositive women: integration of type 16 correlates with rapid progression. Eur J Gynaecol Oncol 1994;15: 50-8.
29. Mainman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Cancer Inst 1998;23:43-9.
30. Maiman M, Fruchter RG, Serur E, Levine PL, Arrastia C, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:170-4.
31. Wright TC, Koulos J, Schnoll F. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994;55:253-8.
32. Stein MD, Cunningham WE, Nakazono T. Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immun Defic Syndr 2001;27:463-6.